Epirizole (Compound)

Synonyms:epirizole, Mepirizole, 18694-40-1, Mebron, Methopyrimazole, 4-Methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methylpyrimidine, Mepirizol, DA-398, Epirizolum [INN-Latin], 4-Methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine, Pyrimidine, 4-methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methyl-, MLS000028844, 3B46O2FH8I, DTXSID4045422, 1-(4-Methoxy-6-methyl-2-pyrimidinyl)-3-methyl-5-methoxypyrazole, 2-(3-Methoxy-5-methylpyrazol-2-yl)-4-methoxy-6-methylpyrimidine, 2-(3-Methyl-5-methoxy-1-pyrazolyl)-4-methoxy-6-methylpyrimidine, NCGC00016737-01, SMR000058715, 4-Methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidin, CAS-18694-40-1, Mepirizol [German], DTXCID2025422, Epirizolum, Epirizol, Epirizol [INN-Spanish], Pyrimidine,4-methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methyl-, Epirizole [USAN:INN:JAN], EINECS 242-507-1, BRN 0751084, UNII-3B46O2FH8I, Prestwick_201, Mebron (TN), EPIRIZOLE [INN], EPIRIZOLE [JAN], Opera_ID_598, EPIRIZOLE [MI], EPIRIZOLE [USAN], Prestwick0_000032, Prestwick1_000032, Prestwick2_000032, Prestwick3_000032, EPIRIZOLE [MART.], 4-Methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidin [German], Epirizole (JP17/USAN), EPIRIZOLE [WHO-DD], SCHEMBL23765, BSPBio_000123, 5-25-18-00012 (Beilstein Handbook Reference), MLS001148256, MLS001424179, SPBio_002044, Mepirizole, analytical standard, BPBio1_000137, CHEMBL1411693, CHEBI:31545, HMS1568G05, HMS2052A07, HMS2095G05, HMS2232E23, HMS3370D19, HMS3394A07, HMS3712G05, Tox21_110584, Pyrimidine, 4-methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methyl-, AKOS016000700, Tox21_110584_1, CCG-101087, DB08991, NC00337, NCGC00016737-02, NCGC00016737-04, HY-103595, CS-0022015, FT-0637738, MLS000028844-02, D01394, SR-01000721915, J-012020, Q5383219, SR-01000721915-3, BRD-K39339537-001-03-8, 2-(3-METHYL-5-METHOXY-1-PYRAZOLYL)-4-METHOXY-6-METHYL-PYRIMIDINE

Pubchem:PUBCHEM:3242

Id:d43cc0b4-60fb-5fae-8eb5-99cdbd71b68b

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Epirizole's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Epirizole.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Epirizole.

Results found

Linked to

	Label	Description
	BRD-K39339537-001-21-0 Substance (Entity type)	A Substance
	epirizole (6112484a-1f7c-42cd-be23-dc842063632e) Collection (Entity type)	Metadatata for epirizole
	DCSTRUCT ID 01029 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01029; PubChem_CID:3242, FILE=drugcentral_drug_01029.json)
	reboxetine in similarity relationship with Epirizole Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Epirizole negatively regulates RPS4Y1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Epirizole negatively regulates RARRES2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Epirizole in similarity relationship with Naftopidil Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Epirizole in similarity relationship with gemifloxacin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Epirizole positively regulates SNAP25 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Epirizole positively regulates KYNU GENE Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS